Key result
Captopril or telmisartan completely prevented the hypoxia-induced loss of the anticontractile effect of perivascular adipose tissue in rat mesenteric small arteries in vitro.
Why the study?
Do captopril or telmisartan prevent the hypoxia-induced loss of anticontractile function of perivascular adipose tissue in rat mesenteric arteries?
Do captopril or telmisartan prevent the hypoxia-induced loss of anticontractile function of perivascular adipose tissue in rat mesenteric arteries?
In a rat model, ACE inhibitors and ARBs prevent the hypoxia-induced loss of the anticontractile function of perivascular adipose tissue, suggesting a mechanism for their vascular benefits in obesity.
No immediate change to clinical practice; leaves open translation of ACEi/ARB perivascular protection from this rat hypoxia model.
BACKGROUND/AIMS: In patients with obesity, there is increased inflammation with attendant oxidative stress in perivascular adipose tissue. This has functional consequences with loss of vasodilator adipokine bioavailability. Part of the inflammatory response is mediated by increased activation of the renin-angiotensin-aldosterone axis. Therefore, this study was designed to investigate whether angiotensin-converting enzyme inhibitors or angiotensin receptor blockers can improve the anticontractile function of perivascular adipose tissue. METHODS: Segments of rat mesenteric small artery were dissected and mounted in a wire myograph and contracted to incremental doses of norepinephrine in the presence and absence of perivascular adipose tissue and in conditions of normal oxygenation or after hypoxia and incubated with captopril or telmisartan. RESULTS: Vessels with perivascular adipose tissue contracted significantly less than arteries with perivascular adipose tissue removed under normal oxygenation conditions, indicating that perivascular adipose tissue exerts an anticontractile effect. Hypoxia induced a loss of this anticontractile effect which could be completely prevented with captopril or telmisartan. CONCLUSION: The in-vitro creation of a hypoxic environment can simulate the loss of anticontractile perivascular adipose tissue function seen in vivo in obese patients, and this can be prevented using inhibitors of the renin-angiotensin cascade.
No takes yet. Share an insight, caveat, or question.
Rosei et al. (2015) studied Obesity-related perivascular adipose tissue dysfunction. Captopril or telmisartan vs. Hypoxia without drug / normal oxygenation was evaluated on Anticontractile function of perivascular adipose tissue (contraction to norepinephrine). Captopril or telmisartan completely prevented the hypoxia-induced loss of the anticontractile effect of perivascular adipose tissue in rat mesenteric small arteries in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: